UK buys potential COVID-19 vaccines from J&J and Novavax

LONDON, Aug 14 (Reuters) - The UK government has sealed two more deals to secure COVID-19 vaccines, buying shots in development from U.S. drugmakers Johnson & Johnson and Novavax Inc, the chair of the UK Vaccine Taskforce Katie Bingham told Sky News on Friday.

In a separate statement, Novavax said the UK would buy 60 million doses of its coronavirus vaccine candidate, NVX-CoV2373, for a phase 3 clinical trial in the country. (Reporting by Alistair Smout; Writing by Josephine Mason; Editing by Jan Harvey)


Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.

Sign up for a free trial of our full service at and follow us on Twitter @Breakingviews and at All opinions expressed are those of the authors.